These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8981596)

  • 61. Both long and brief maternal separation produces persistent changes in tissue levels of brain monoamines in middle-aged female rats.
    Arborelius L; Eklund MB
    Neuroscience; 2007 Mar; 145(2):738-50. PubMed ID: 17222517
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of neonatal clomipramine treatment on locomotor activity, anxiety-related behavior and serotonin turnover in Syrian hamsters.
    Yannielli PC; Kargieman L; Gregoretti L; Cardinali DP
    Neuropsychobiology; 1999 May; 39(4):200-6. PubMed ID: 10343185
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Behavioral effects of neonatal treatment with clomipramine, scopolamine, and idazoxan in male rats.
    Velazquez-Moctezuma J; Aguilar-Garcia A; Diaz-Ruiz O
    Pharmacol Biochem Behav; 1993 Sep; 46(1):215-7. PubMed ID: 7902983
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of neonatal clomipramine on cholinergic receptor sensitivity and passive avoidance behavior in adult rats.
    Prathiba J; Kumar KB; Karanth KS
    J Neural Transm Gen Sect; 1995; 100(2):93-9. PubMed ID: 8962688
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Androgen-dependent sex differences in the hypothalamic serotoninergic system.
    Borisova NA; Proshlyakova EV; Sapronova AY; Ugrumov MV
    Eur J Endocrinol; 1996 Feb; 134(2):232-5. PubMed ID: 8630525
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibitory effect of clomipramine and related drugs on serotonin uptake in platelets: more complicated than previously thought.
    Lingjaerde O
    Psychopharmacology (Berl); 1979 Mar; 61(3):245-9. PubMed ID: 109887
    [No Abstract]   [Full Text] [Related]  

  • 67. Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments?
    Drago F; Nicolosi A; Micale V; Lo Menzo G
    Eur Neuropsychopharmacol; 2001 Jun; 11(3):209-13. PubMed ID: 11418280
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical pharmacological studies of tandamine, a potential antidepressive drug.
    Ehsanullah RS; Ghose K; Kirby MJ; Turner P; Witts D
    Psychopharmacology (Berl); 1977 Mar; 52(1):73-7. PubMed ID: 403562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunological parameters of the blood and monoamine content in the brain of rats during long-term overcrowding.
    Loseva EV; Loginova NA; Mezentseva MV; Klodt PM; Kudrin VS
    Bull Exp Biol Med; 2013 Aug; 155(4):470-3. PubMed ID: 24143371
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Animal depression model by neonatal clomipramine: reduction of shock induced aggression.
    Vogel G; Hartley P; Neill D; Hagler M; Kors D
    Pharmacol Biochem Behav; 1988 Sep; 31(1):103-6. PubMed ID: 3252240
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pain sensitivity in major depression and its relationship to central serotoninergic function as reflected by the neuroendocrine response to clomipramine.
    Kundermann B; Hemmeter-Spernal J; Strate P; Gebhardt S; Huber MT; Krieg JC; Lautenbacher S
    J Psychiatr Res; 2009 Dec; 43(16):1253-61. PubMed ID: 19467668
    [TBL] [Abstract][Full Text] [Related]  

  • 72. On a mechanism for the mood and personality changes of adult and later life. A psychobiological hypothesis.
    Mandell AJ
    J Nerv Ment Dis; 1979 Aug; 167(8):457-66. PubMed ID: 469508
    [No Abstract]   [Full Text] [Related]  

  • 73. Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.
    Glover ME; Clinton SM
    Int J Dev Neurosci; 2016 Jun; 51():50-72. PubMed ID: 27165448
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.
    Glover ME; Pugh PC; Jackson NL; Cohen JL; Fant AD; Akil H; Clinton SM
    Neuroscience; 2015 Jan; 284():775-797. PubMed ID: 25451292
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of fluoxetine on disease progression in a mouse model of ALS.
    Koschnitzky JE; Quinlan KA; Lukas TJ; Kajtaz E; Kocevar EJ; Mayers WF; Siddique T; Heckman CJ
    J Neurophysiol; 2014 Jun; 111(11):2164-76. PubMed ID: 24598527
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Developmental exposure to fluoxetine modulates the serotonin system in hypothalamus.
    Berg C; Backström T; Winberg S; Lindberg R; Brandt I
    PLoS One; 2013; 8(1):e55053. PubMed ID: 23383055
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sleep-related epilepsy in a Long-Evans hooded rat model of depression.
    McDowell AL; Strohl KP; Feng P
    Sleep Breath; 2012 Dec; 16(4):1181-91. PubMed ID: 22205358
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine.
    Feng P; Vurbic D; Wu Z; Hu Y; Strohl KP
    J Psychopharmacol; 2008 Sep; 22(7):784-91. PubMed ID: 18753273
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment.
    Maciag D; Williams L; Coppinger D; Paul IA
    Eur J Pharmacol; 2006 Feb; 532(3):265-9. PubMed ID: 16483567
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.
    Maciag D; Simpson KL; Coppinger D; Lu Y; Wang Y; Lin RC; Paul IA
    Neuropsychopharmacology; 2006 Jan; 31(1):47-57. PubMed ID: 16012532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.